ロード中...
Combination dolutegravir–abacavir–lamivudine in the management of HIV/AIDS: clinical utility and patient considerations
The current standard of care for human immunodeficiency virus (HIV) treatment is a three-drug regimen containing a nonnucleoside reverse transcriptase inhibitor, a protease inhibitor, or an integrase strand transfer inhibitor (INSTI) plus two nucleoside/tide reverse transcriptase inhibitors. Given t...
保存先:
| 出版年: | Patient Prefer Adherence |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4337619/ https://ncbi.nlm.nih.gov/pubmed/25733823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S65199 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|